Home/Filings/4/0001626199-24-000073
4//SEC Filing

GOLD MITCHELL 4

Accession 0001626199-24-000073

CIK 0001626199other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 7:24 PM ET

Size

9.2 KB

Accession

0001626199-24-000073

Insider Transaction Report

Form 4
Period: 2024-05-08
GOLD MITCHELL
DirectorExecutive Chairman and CEO10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-08$7.55/sh+13,245$100,000109,245 total
  • Exercise/Conversion

    Stock Option (Right to buy)

    2024-05-0813,245336,755 total
    Exercise: $7.55Exp: 2033-01-03Common Stock (13,245 underlying)
Holdings
  • Common Stock

    (indirect: Alpine ImmunoSciences, L.P.)
    2,627,157
Footnotes (5)
  • [F1]Includes 96,000 shares of common stock underlying a restricted stock unit grant made on January 4, 2024.
  • [F2]Alpine BioVentures GP, LLC is the general partner of Alpine ImmunoSciences, L.P. Dr. Gold is a Managing Partner of Alpine BioVentures GP, LLC. Dr. Gold is also a limited partner of Alpine ImmunoSciences, L.P. By virtue of such relationships, Dr. Gold may be deemed to have voting and investment power with respect to the shares held by Alpine ImmunoSciences, L.P. and as a result may be deemed to have beneficial ownership of such shares.
  • [F3]The Reporting Person disclaims beneficial ownership of the shares of common stock reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  • [F4]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
  • [F5]One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.

Issuer

ALPINE IMMUNE SCIENCES, INC.

CIK 0001626199

Entity typeother

Related Parties

1
  • filerCIK 0001242882

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 7:24 PM ET
Size
9.2 KB